Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia

Amanda Przespolewski; Aaron D. Goldberg; Chetasi Talati; Salman Fazal; Pankit Vachhani; Srinivasa R. Sanikommu; Swapna Thota; Julian Waksal; Brian Ball; Christopher Famulare; Maximilian Stahl; Jeffrey Baron; Elizabeth A. Griffiths; James E. Thompson; Kendra Sweet; Eunice S. Wang

doi:10.1182/blood.2022016678

Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia

Amanda Przespolewski
, Aaron D. Goldberg
, Chetasi Talati
, Salman Fazal
, Pankit Vachhani
, Srinivasa R. Sanikommu
, Swapna Thota
, Julian Waksal
, Brian Ball
, Christopher Famulare
, Maximilian Stahl
, Jeffrey Baron
, Elizabeth A. Griffiths
, James E. Thompson
, Kendra Sweet
, Eunice S. Wang

Office of Research Compliance

Roswell Park Cancer Institute
Memorial Sloan-Kettering Cancer Center
Moffitt Cancer Center
AbbVie
West Penn Allegheny Health System
University of Alabama at Birmingham
Levine Cancer Institute
University of Tennessee Health Science Center
Icahn School of Medicine at Mount Sinai
City of Hope National Med Center
Dana-Farber Cancer Institute

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	1489-1493
Number of pages	5
Journal	Blood
Volume	141
Issue number	12
DOIs	https://doi.org/10.1182/blood.2022016678
State	Published - Mar 23 2023

Access to Document

10.1182/blood.2022016678

Cite this

Przespolewski, A., Goldberg, A. D., Talati, C., Fazal, S., Vachhani, P., Sanikommu, S. R., Thota, S., Waksal, J., Ball, B., Famulare, C., Stahl, M., Baron, J., Griffiths, E. A., Thompson, J. E., Sweet, K., & Wang, E. S. (2023). Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia. Blood, 141(12), 1489-1493. https://doi.org/10.1182/blood.2022016678

@article{adfc353354d246978b1c688570e59767,

title = "Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia",

author = "Amanda Przespolewski and Goldberg, \{Aaron D.\} and Chetasi Talati and Salman Fazal and Pankit Vachhani and Sanikommu, \{Srinivasa R.\} and Swapna Thota and Julian Waksal and Brian Ball and Christopher Famulare and Maximilian Stahl and Jeffrey Baron and Griffiths, \{Elizabeth A.\} and Thompson, \{James E.\} and Kendra Sweet and Wang, \{Eunice S.\}",

year = "2023",

month = mar,

day = "23",

doi = "10.1182/blood.2022016678",

language = "English",

volume = "141",

pages = "1489--1493",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "12",

}

Przespolewski, A, Goldberg, AD, Talati, C, Fazal, S, Vachhani, P, Sanikommu, SR, Thota, S, Waksal, J, Ball, B, Famulare, C, Stahl, M, Baron, J, Griffiths, EA, Thompson, JE, Sweet, K & Wang, ES 2023, 'Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia', Blood, vol. 141, no. 12, pp. 1489-1493. https://doi.org/10.1182/blood.2022016678

TY - JOUR

T1 - Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia

AU - Przespolewski, Amanda

AU - Goldberg, Aaron D.

AU - Talati, Chetasi

AU - Fazal, Salman

AU - Vachhani, Pankit

AU - Sanikommu, Srinivasa R.

AU - Thota, Swapna

AU - Waksal, Julian

AU - Ball, Brian

AU - Famulare, Christopher

AU - Stahl, Maximilian

AU - Baron, Jeffrey

AU - Griffiths, Elizabeth A.

AU - Thompson, James E.

AU - Sweet, Kendra

AU - Wang, Eunice S.

PY - 2023/3/23

Y1 - 2023/3/23

UR - https://www.scopus.com/pages/publications/85148855505

U2 - 10.1182/blood.2022016678

DO - 10.1182/blood.2022016678

M3 - Article

C2 - 36493344

AN - SCOPUS:85148855505

SN - 0006-4971

VL - 141

SP - 1489

EP - 1493

JO - Blood

JF - Blood

IS - 12

ER -

Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia

Access to Document

Other files and links

Fingerprint

Cite this